These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8526343)

  • 41. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

  • 42. Confusion reigns over breast cancer.
    Birmingham K
    Nat Med; 2001 Dec; 7(12):1266. PubMed ID: 11726953
    [No Abstract]   [Full Text] [Related]  

  • 43. Should tamoxifen be used in breast cancer prevention?
    Kramer R; Brown P
    Drug Saf; 2004; 27(13):979-89. PubMed ID: 15471505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trials referral resource. Breast cancer and prostate cancer.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
    [No Abstract]   [Full Text] [Related]  

  • 45. Tamoxifen-related porphyria cutanea tarda.
    Agarwal R; Peters TJ; Coombes RC; Vigushin DM
    Med Oncol; 2002; 19(2):121-3. PubMed ID: 12180481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Narod S
    J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
    [No Abstract]   [Full Text] [Related]  

  • 47. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward optimal health: the experts discuss tamoxifen and breast cancer prevention. Interview by Jodi Godfrey Meisler.
    Ford E; Greenwald P
    J Womens Health; 1998 Jun; 7(5):513-7. PubMed ID: 9650151
    [No Abstract]   [Full Text] [Related]  

  • 49. Experts debate drugs for healthy women with breast cancer risk.
    Stephenson J
    JAMA; 1999 Jul; 282(2):117-8. PubMed ID: 10411178
    [No Abstract]   [Full Text] [Related]  

  • 50. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen for the prevention of breast cancer.
    Fisher B; Powles TJ; Pritchard KJ
    Eur J Cancer; 2000 Jan; 36(2):142-50. PubMed ID: 10741272
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemoprevention of breast cancer.
    Cuzick J
    Breast Cancer; 2008; 15(1):10-6. PubMed ID: 18224388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?
    Bergh J
    Lancet; 2003 Jul; 362(9379):183-4. PubMed ID: 12885476
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prevention of breast cancer using tamoxifen].
    Foidart JM; Colin C; Lifrange E
    Rev Med Liege; 1998 Apr; 53(4):225-6. PubMed ID: 9641022
    [No Abstract]   [Full Text] [Related]  

  • 55. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
    Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
    Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamoxifen and the induction of cancer.
    King CM
    Carcinogenesis; 1995 Jul; 16(7):1449-54. PubMed ID: 7614676
    [No Abstract]   [Full Text] [Related]  

  • 58. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Day R; Ganz PA; Costantino JP; Cronin WM; Wickerham DL; Fisher B
    J Clin Oncol; 1999 Sep; 17(9):2659-69. PubMed ID: 10561339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant therapy in breast cancer. Optimal use in the elderly.
    Plowman PN
    Drugs Aging; 1996 Sep; 9(3):185-90. PubMed ID: 8877312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current approaches to breast cancer prevention.
    Henderson M
    Science; 1993 Jan; 259(5095):630-1. PubMed ID: 8430311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.